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We have undertaken an observational retrospective cohort study to assess feasibility and
clinical effectiveness of early rehabilitation in patients recovering from acute exacerbation
of COPD (AECOPD).
A cohort of 1826 inpatients (73% male, age 70  8 yrs, FEV1 50  16% pred.) admitted to
a pulmonary rehabilitation (PR) program and completing at least 15 sessions were divided into
categories according to their dyspnoea grade (Medical Research Council e MRC scores 2e5) as
assessed before AECOPD. The preepost changes in 6-minute walking distance (6MWD) test,
perceived end-effort dyspnoea (Borg scale), and self-reported quality of life (St. George’s
respiratory Questionnaire: SGRQ) were measured throughout.
Absolute change in 6MWD (52 [95%CI 45e59], 65 [95%CI 60e70], 63 [95%CI 59e66], and 70
[95%CI 67e74] meters in MRC 2e5 respectively) and the percentage of patients achieving
the minimal clinically important difference (MCID) of þ54 m (40, 55, 57, and 61%, respectively,
pZ 0.001) differed across MRC grades. Proportion of patients able to reach 350 m at the
6MWD after PR was higher in MRC 4 and 5 (18 and 22%) as compared to MRC 2 and 3 (6 and 15%).
Early PR in a cohort of AECOPD patients is feasible and it is associated to clinically meaning-
ful improvement in exercise tolerance independent on the severity of dyspnoea. The propor-
tion of patients reaching the limit of 350 m after this intervention is higher in the most severe
patients.
ª 2009 Elsevier Ltd. All rights reserved.odena and Ospedale Villa Pineta, Division of Pulmonary Rehabilitation, Via Gaiato 127, 41026 Pavullo
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Exercise tolerance in patients with chronic obstructive
pulmonary disease (COPD) declines progressively in the
natural course of the disease.1 Pulmonary rehabilitation
(PR) should be considered for all patients with chronic
respiratory disease who have persistent symptoms and
limited activity.2 This therapy has been shown to improve
physical performance in COPD patients both in the short3
and long-term.4 The severity of dyspnoea as assessed by the
Medical Research Council (MRC) scale may be an appro-
priate guide for patient selection.5
Overall, the individual’s perceived exercise improve-
ment after treatment poorly correlates with the absolute
change in the moderate to severe stable COPD.6 Nonethe-
less, AECOPD is an important cause of deterioration in lung
function and health-related quality of life (HRQL).7,8
Despite optimal medical therapy AECOPD patients take
considerable time to recover to baseline levels of their
physical functioning, with 25% of them who do not fully
recover the peak-flow level after three months,9 and with
the patient’s ability to perform physical activity very hard
to recover in the near follow-up.10
A previous controlled study of early outpatient PR in
a small sample following hospitalized AECOPD, has sug-
gested that patients continue to deteriorate in the absence
of rehabilitation3; notwithstanding, the likely significance
of change in exercise tolerance at the end of PR following
AECOPD is still poorly evaluated in this population.3,11
In this retrospective cohort study on inpatients we aimed
at assessing both feasibility and clinical effectiveness of
early PR after AECOPD.
Methods
Patients
We have retrospectively reviewed data sets of consecutive
COPD patients referred to a inpatient PR program at our
regional centre (Villa Pineta Hospital, Pavullo n/F, Italy)
since January 2006 to December 2007. They were all
admitted after AECOPD either requiring hospital admission
or outpatient therapies. Inpatient PR is the modality of
choice in Italy as well as in other European countries; thus,
patients moved to rehabilitation centre both after
discharge from acute hospitals or from their home or
community centres. In all cases referral to PR was within 10
days following the acute care as described above.3
This study consisted of a preepost design with outcome
measurements taken throughout PR. Comparison was per-
formed only in those patients (nZ 1826) who completed
a minimum of 15 rehabilitation sessions (see below). The
study flow-chart is displayed in Fig. 1.
Diagnosis and severity of COPD were confirmed in all
patients by spirometry performed when stable in the 6-
month before exacerbation, and defined according to the
Global Initiative for Chronic Obstructive Lung Disease
(GOLD) guidelines.12 A co-morbidity score, Charlson
Index,13 was computed (not adjusted by age) for all of
them. Patients were graded by their level of dyspnoea as
assessed by the Medical Research Council (MRC) scale14,15when in stable state. This chronic dyspnoea scale contain-
ing five levels of severity (from 1 as the mildest to 5 as the
worst), has been shown to reflect the beneficial effects of
PR16 and to provide clinically important prognostic infor-
mation in COPD patients.17 All data concerning the
patient’s characteristics when in stable state were taken
from the hospital labs’ or the GPs’ database.
Six patients in MRC grade 1 were excluded from analysis
due to the small number. Patients with any other pulmo-
nary disease (i.e. bronchial asthma or restrictive disease)
were also excluded from data collection. Furthermore, we
have also excluded those COPD patients with co-existing
limitation to exercise or with other associated conditions
(i.e. unstable angina, advanced cardiac failure, cardiac
valve dysfunctions) which may have limited or impaired
response to training.
The institutional review board at the Villa Pineta
Hospital approved this study.
Rehabilitation program
Patient’s selection and the delivered comprehensive
program were according to the ATS/ERS joint statement.2 In
particular, this inpatient program has been reported previ-
ously by our group18; briefly, each daily session included
mixed physical training based on endurance (on a cycle or
treadmill) and resistance of the peripheral muscles; exercise
intensity (up to 80% of the sustainable load at baseline) and
duration (up to 30 min/session) were gradually progressed
1528 E.M. Clini et al.over time as previously recommended.19,20 Education and
full psychological and/or nutritional support (if indicated)
completed the program. Duration of PR was over a minimum
of 4 working weeks and 15 consecutive sessions (6 daily
session/week, mean 18 3).
Study outcomes
Measurements in our institute were taken 48 h since
admission (baseline) and after a minimum of 15 rehabili-
tation sessions (end of PR) was reached.
Walking capacity was assessed by the six-minute walking
distance test (6MWD) according to the recommended
guidelines.21 The best of two consecutive tests conducted
in a 30-m long and 3-m wide corridor (at a minimum
distance of 2-h) under quiet conditions and without
distractive stimuli was recorded for analysis.
The individual’s perceived peak effort dyspnoea (D) at
the end of 6MWD was measured by pointing to a number or
phrase on a 10-point modified Borg scale22 set in large type
on a sheet; this assessment was made during the last
minute of walking.
Health-related quality of life was assessed by the self-
administered Italian version of the St. George’s Respiratory
Questionnaire (SGRQ)23: the total and each component
scores (activity, symptoms, impact) of the questionnaire
were recorded.
Statistical analysis
Analyses were carried out using SPSS software (SPSS 11.0
for Windows; SPSS, Chicago, Illinois, USA). Qualitative
variables are expressed as percentages; quantitative vari-
ables are expressed as means (SD). Absolute changes (D)
and percentage of patients reaching the minimal clinically
important difference (MCID)24 after PR in each outcome
(þ54 at 6MWD, 1 Borg point, 4 SGRQ total score) were
assessed. The number and proportion of patients able to
reach the absolute value of 350 m at 6MWD after PR was
also considered across MRC grades.
One way analysis of variance (ANOVA) was used to test any
difference in absolute changes, whereas univariate method
(Chi-square test) was used to compare percentage changes
across the MRC categories. Finally, Pearson’s correlation
coefficient analysis among outcomes (both as absolute values
or changes after PR) was also applied. A p-value lower than
0.05 was considered to be statistically significant.
Results
AECOPD patients represented 89% of all patients admitted
for rehabilitation purposes in Villa Pineta centre over the
considered period; the study cohort of interest with 1826
patients (93% of total) completed a minimum of 15 PR
sessions (see also in Fig. 1).
Table 1 displays the general characteristics of the study
population. As expected, co-morbidity score, lung function
and exercise capacity progressively worsen across MRC
categories 2e5.
Outcome changes at the end of PR are shown in Table 2.
Changes in 6WMD, but not in other outcomes, significantlydiffered according to the MRC grade. The relative propor-
tion of COPD patients who reached the MCID at the 6MWD
(þ54 m) after PR was 40, 55, 57 and 61% in MRC 2, 3, 4 and 5
respectively (p< 0.001).
The correlation coefficient analysis showed that none of
the observed changes in outcome measures was signifi-
cantly correlated to baseline values. Lack of correlation
was also found among changes in different outcomes when
considering the whole cohort or the MRC categories.
Table 3 displays the number and proportion of patients
who reached the MCID and the absolute value of 350 m at
the 6MWD as measured throughout rehabilitation. Both
number and % of patients reaching this 350 m limit were
different across MRC grades (pZ 0.001 at the Chi-square
test); proportion was higher in patients with worst disability
status (MRC 4 and 5) as compared with others.Discussion
This study has shown that inpatient PR is feasible and
results in clinically meaningful improvement in 6MWD in
a cohort of AECOPD patients independent on their MRC
grade. A higher number and proportion of patients in MRC 4
and 5 was able to reach the pre-defined MCID for 6MWD, but
not for other outcomes; moreover, a higher number and
proportion of the same patients reached the limit of
350 m at the 6MWD after PR.
Overall, COPD patients of all severity grades may benefit
from PR5 when in stable state, despite those patients with
a disability status graded 5 at the MRC scale are less likely
to gain.15 AECOPD imposes a substantial burden in the
disease progression also affecting the perceived health
status.10,25 Therefore, it is likely that AECOPD patients have
a poorer physical condition and a higher risk of read-
mission.26 Hospitalized AECOPD patients continue to dete-
riorate in the absence of rehabilitation,3 which therefore
makes an early PR course a reasonable option to prevent
any further loss in function and clinical deterioration.27,28
First, the present study has shown that ‘‘early’’ inpa-
tient PR is feasible in a population referred to PR after
AECOPD; only 7% of the population of interest failed to
complete a minimum of 15 sessions, which is expected to
be a useful limit for effective training during rehabilitation
period.2,12
Second, and quite interestingly, the absolute improve-
ment and the proportion of patients reaching the MCID in
6MWD (but not of Borg-dyspnoea or SGRQ) after PR was
greater in those AECOPD with MRC grade 5 (see Table 2).
This result corroborates previous findings showing that, in
term of MCID, a proportion of 50e65% of COPD across MRC
grades can be defined as improved after PR.2,29 Further-
more, this finding extends to AECOPD this observation.
We have used MRC classification to assess the subjects’
perception of disability30 as referred to the stable condi-
tion. Indeed, in COPD there is a well-described cycle of
decline for the exertional symptoms (the so called ‘‘vicious
circle’’) which reflects the MRC level. Previous papers
report that it may be possible to interrupt this cycle at any
MRC grade,15,30,31 even when following AECOPD.3,11
The magnitude of benefit in exercise performance after
PR may vary consistently depending on several individual’s
Table 1 Characteristics of patients in the study cohort as assessed when in stable state (before AECOPD). Mean (SD).
All patients MRC score p
2 3 4 5
Patients, nr (%) 1.826 150 (8.2) 304 (16.6) 594 (32.5) 778 (42.7)
Age, years 70.8 (8.4) 68.7 (9.1) 69.6 (8.8) 70.8 (8.0) 71.5 (8.2) 0.001
Sex, M/F nr 1413/525 124/34 222/98 472/158 595/235 0.093
BMI, kg/m2 24.2 (4.0) 25.1 (3.6) 25.9 (4.3) 24.2 (2.2) 23.9 (1.9) 0.536
Charlson index 4.78 (1.58) 4.37 (1.17) 4.80 (1.64) 4.66 (1.63) 5.31 (1.75) 0.001
FEV1, % pred. 50.5 (16.6) 54.3 (15.7) 51.4 (15.9) 51.7 (16.1) 46.7 (17.3) 0.001
GOLD stage, no. (%) 0.001
I 80 (4.4) 8 12 31 29
II 765 (41.8) 70 122 254 319
III 617 (33.7) 62 84 201 270
IV 364 (21.1) 10 92 101 161
LTOT, nr (%) 349 (19.1) 10 (1.8) 76 (21.7) 90 (25.8) 173 (49.3)
PaO2/FiO2 257.6 (56.8) 253.3 (55.7) 248.2 (53.9) 263.4 (49.8) 261.0 (60.1) 0.348
PaCO2, mmHg 43.7 (8.7) 44.0 (7.5) 42.3 (7.8) 43.0 (7.3) 45.2 (8.9) 0.741
FEV1Z forced expiratory volume in the 1st second; 6MWDZ six-minute walked distance; SGRQZ St. George’s Respiratory Question-
naire; LTOTZ long-term oxygen therapy; PaO2Z arterial oxygen tension; PaCO2Z arterial carbon dioxide tension; and FiO2Z fraction
of inspired oxygen.
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performance at which the COPD patient is at the beginning
of rehabilitation course. In particular, those patients naı¨ve
from prior rehabilitation32 have been shown to improve
more than others, thus suggesting the important contribu-
tion that PR per se may have in respect of the recovery of
physical performance.
An increase greater than 54 m (range 31e70) in the
6MWD has been so far proposed as the MCID after PR in
COPD outpatients.33 In addition, COPD patients with the
ability to perform 350e361 m at the 6MWD were those
likely to live better1 and longer.34,35 Following our results,
it may appear questionable whether this MCID in the 6MWD
could meaningfully adapt to patients recovering from an
acute condition with adjunctive associated disability. In
a recent meta-analysis, Puhan and coworkers6 extensively
discussed the likely significance of treatment change of
6MWD in COPD patients of comparable severity and
disability. They concluded that 6MWD should change by
approximately 35 m in these individuals in order to repre-
sent a least important effect; moreover, they suggested
that the clinical important effect would better correspond
to a 10% change of baseline value. This seems more
reasonable in order to normalize data; indeed, it was
perfectly in line with findings across all the MRC categoriesTable 2 Absolute changes of the outcome variables at the end
All patients
(nZ 1826)
MRC categories
2 (nZ 150)
D 6MWD (m) mean (SD)
[95% CI]
65.3 (48.0)
[63.2e67.5]
51.9 (44.5)
[44.9e58.9]
D Dyspnea (BORG scale)
mean (SD) [95% CI]
1.68 (1.56)
[1.76e1.60]
1.69 (1.48)
[1.94e1.45]
D SGRQ (total score)
mean (SD) [95% CI]
5.89 (10.0)
[6.45e5.34]
6.53 (8.40)
[9.49e3.21]
See Table 1. *p< 0.05 and ^p< 0.001 versus MRC 2; and xp< 0.01 ver(þ12, þ17, þ17 and þ20% in MRC 2e5, respectively,
p< 0.05) in the present cohort of AECOPD patients.
The lack of difference of gain reached after PR in other
outcomes (dyspnoea and HRQL) across MRC grades further
reinforces finding related to 6MWD change in favour of the
most sick patients. Indeed, this particular effect might
favour those individuals with lower exercise performance
and higher risk of developing new exacerbations.36
The second interesting result in the present study
appears, in our opinion, the greater proportion of patients
who improved and were able to reach the threshold level
of 350 m at the 6 MWD after PR (see Table 3). These
patients accounted by 18% out of the whole cohort, and
again they were more prevalent among those with higher
MRC grades; in particular, about one fourth of MRC 5
patients were able to obtain this gain after intensive
training.
At a first glance, this result might appear of secondary
importance. Notwithstanding, 6MWD change over time is
a independent predictor of mortality,37 with the absolute
level of 350 m as the threshold associated with the best
probability rate (higher than 40%) of 8-yrs survival.34 We
can therefore speculate that this inpatient program would
have contributed to turn the most compromised patients
from the perspective of a worse long-term prognosis.of PR in the study cohort.
p
3 (nZ 304) 4 (nZ 594) 5 (nZ 778)
65.2* (46.8)
[60.0e70.4]
62.3 (45.8)
[58.7e65.9]
70.3^x (50.2)
[66.9e73.7]
0.001
1.76 (1.54)
[2.17e1.80]
1.72 (1.57)
[1.67e1.38]
1.68 (1.57)
[1.78e1.53]
0.104
6.76 (9.66)
[8.54e4.97]
6.14 (10.40)
[7.10e5.19]
5.55 (9.98)
[6.31e4.78]
0.582
sus MRC 4.
Table 3 Number and proportion of patients who reached the MCID and the limit of 350 m at the 6MWD in the preepost
comparison throughout rehabilitation period.
All patients (nZ 1826) MRC categories
2 (nZ 150) 3 (nZ 304) 4 (nZ 594) 5 (nZ 778)
Improved and able
to reach 350 m
n (%) 317 (17.3) 7 (4.6) 43 (14.1) 100 (16.8) 167 (21.4)
Improved but NOT able
to reach 350 m
n (%) 706 (38.6) 52 (34.6) 122 (40.1) 228 (38.3) 304 (39.0)
ImprovedZ change of 54 m at the 6MWD post-PR, pZ 0.001 at the Chi-square test.
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Despite the apparently interesting benefits observed in
a large cohort of patients after AECOPD, some limitations
need to be carefully addressed by readers.
First and most important, the retrospective nature of
the study does not authorise to automatically translate
findings in a future prospective trial which therefore needs
to be considered.
Second, criteria of disability and patients’ selection
might clearly have influenced results; we have here used
MRC which is recognised a useful tool to assess and classify
the individual’s disability through self-recalled activity/
dyspnoea in COPD, but does not provide complete indica-
tion on the degree of severity concerning extra-pulmonary
features in patients entering rehabilitation.38 Moreover, in
these AECOPD patients we cannot exclude that convales-
cence period itself may have contributed to restore (at
least partially) the residual individual’s capacities not
related with the specific training program.
Third, we can only speculate that reaching a better
performance status would have been associated with
a better prognosis; moreover, the limit of 350 m as for
a prognostic indicator of survival still need to be further
confirmed in COPD population.
We then conclude that early inpatient rehabilitation is
feasible and provides clinically relevant change of exercise
tolerance across all the MRC grades in a large cohort of
patients after AECOPD. The proportion of patients who
improved their performance and reached the limit of
350 m after rehabilitation is higher in patients with the
worst baseline disability.
From a clinical point of view, these results expand the
recent findings by Evans et al.31 who found benefits from PR
in stable outpatient COPD independent of their MRC grade.
Our results would then alert clinicians to prompt rehabili-
tation program after exacerbation whatever is the degree
of severity, and to consider the most sick and disabled
patients as those who are most likely to benefit.
This study warrants further prospective investigations to
confirm results or even to expand likely significance of
change of different PR outcomes in these patients.Acknowledgments
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